Anúncio
Anúncio
TENX
Tenax Therapeutics, Inc.
13.28
USDPatrocinado
+0.16
+1.18%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
13.28
0.00
0.00%
Relatórios de Lucros TENX
Rácio de surpresa positiva
TENX separação 20 de 37 últimas estimativas.
54%
Próximo Relatório
Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.42
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+5.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+133.33%
Tenax Therapeutics, Inc. earnings per share and revenue
On 12 de nov. de 2025, TENX reported earnings of -0.40 USD per share (EPS) for Q3 25, missing the estimate of -0.31 USD, resulting in a -25.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analistas forecast an EPS of -0.42 USD, with revenue projected to reach -- USD, implying an aumentar of 5.00% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Tenax Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Tenax Therapeutics, Inc. reported EPS of -$0.40, missing estimates by -25.47%, and revenue of $0.00, 0% as expectations.
How did the market react to Tenax Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved down -4.29%, changed from $6.99 before the earnings release to $6.69 the day after.
When is Tenax Therapeutics, Inc. expected to report next?
The next earning report is scheduled for 23 de mar. de 2026.
What are the forecasts for Tenax Therapeutics, Inc.'s next earnings report?
Based on 7
analistas, Tenax Therapeutics, Inc. is expected to report EPS of -$0.42 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio